Shanghai Zj Bio-Tech Co.Ltd(688317)
Short form equity change report
Name of listed company: Shanghai Zj Bio-Tech Co.Ltd(688317) place of stock listing: Shanghai Stock Exchange Stock abbreviation: Shanghai Zj Bio-Tech Co.Ltd(688317) Stock Code: 688317 information disclosure obligor: Panxin (Shanghai) Equity Investment Center (limited partnership) domicile: China (Shanghai) Room 249, No. 4-5, Lane 37, Zhangjiabang Road, pilot Free Trade Zone, mailing address: 15 / F, Jinbao building, No. 89 Jinbao Street, Dongcheng District, Beijing. Nature of equity change: reduction of shares
Signed on: February 24, 2022
Statement of information disclosure obligor
1、 This report is prepared by the information disclosure obligor in accordance with the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the content and format of information disclosure by companies offering securities to the public No. 15 – Report on changes in equity and other relevant laws and regulations.
2、 The information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with any provision in the articles of association or internal rules of the information disclosure obligor.
3、 In accordance with the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, and the standards for the contents and forms of information disclosure by companies offering securities to the public No. 15 – Report on changes in equity and other relevant provisions, This report has fully disclosed the changes in shares in which the information disclosure obligor has interests in Shanghai Zj Bio-Tech Co.Ltd(688317) (hereinafter referred to as ” Shanghai Zj Bio-Tech Co.Ltd(688317) “, “listed company” and “company”). As of the signing date of this report, except for the information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Shanghai Zj Bio-Tech Co.Ltd(688317) by any other means.
4、 There are no other additional effective conditions for this equity change. This equity change is based on the information stated in this report. Except for the information disclosure obligor, no unit or individual has been entrusted or authorized to provide the information not listed in this report and make any explanation and explanation to this report.
5、 The information disclosure obligor promises that there are no false records, misleading statements or major omissions in this report, and will bear individual and joint legal liabilities for its authenticity, accuracy and completeness.
catalogue
Section 1 interpretation Section 2 information disclosure obligors Section III purpose of equity change and shareholding plan Section IV equity change method 8 section 5 trading of shares of Listed Companies in the first six months Section VI other major matters Section VII declaration of information disclosure obligor Section VIII documents for future reference 12. Short form equity change report thirteen
Section I interpretation
In this report, unless the context otherwise requires, the following abbreviations have the following specific meanings: listed company, company, Zhizhi Shanghai Zj Bio-Tech Co.Ltd(688317) Jiang biological information disclosure obligor, Panzhi Panxin (Shanghai) Equity Investment Center (limited partnership) investment
The report and this report refer to the Shanghai Zj Bio-Tech Co.Ltd(688317) simplified equity change report
From February 22 to February 23, 2022, the information disclosure obligor reduced the shares of listed companies by means of centralized bidding, with a total of 513000 equity changes
(accounting for 0.26% of the total share capital of the listed company), and the equity change with the shareholding ratio less than 5% after the reduction.
Shanghai stock exchange refers to Shanghai Stock Exchange
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
Section 2 information disclosure obligors
1、 Basic information of information disclosure obligor
As of the date of issuance of this report, the basic information of information disclosure obligors is as follows:
Company name: Panxin (Shanghai) Equity Investment Center (limited partnership)
Type of enterprise: limited partnership
Registered address: room 249, No. 4-5, Lane 37, Zhangjiabang Road, China (Shanghai) pilot Free Trade Zone
Date of establishment: August 30, 2011
Operation period: August 29, 2026
Executive partner Shanghai Yude equity investment center (limited partnership)
Executive partner appoints representative Tian Yu
Unified social credit Code: 91310000582062390q
Business scope: equity investment, industrial investment, investment management, investment consulting. [for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments]
Mailing address: 15 / F, Jinbao building, No. 89 Jinbao Street, Dongcheng District, Beijing
Major partners and capital contributions:
Subscribed capital contribution subscribed capital contribution ratio serial number partner name
(10000 yuan) case (%)
1 Shanghai Yude equity investment center (limited partnership) 1 0.0002
2 Beijing Xinyu Investment Center (limited partnership) 506223 99.9998
Total – 506224 100
Note: the discrepancy between the total and the mantissa of the sum of the sub item values is caused by rounding.
2、 Information about the principal of the information disclosure obligor
The main persons in charge of the information disclosure obligor are as follows:
Whether long-term residence has obtained the name, gender, position and nationality of other countries
Right of abode in place or region
Tian Yunan executive partnership Beijing, China no
Appointed representative
3、 Shares of other listed companies owned by information disclosure obligors
As of the signing date of this report, the information disclosure obligor does not hold shares of other domestic and overseas listed companies with interests up to or exceeding 5% of the issued shares of the company.
Section III purpose of equity change and shareholding plan
1、 Purpose of this equity change
The reason for this equity change is that the business operation of the information disclosure obligor needs to reduce the shares of the listed company.
2、 Shareholding plan of information disclosure obligor in the next 12 months
1. The company disclosed the announcement of Shanghai Zj Bio-Tech Co.Ltd(688317) shareholders’ share reduction plan through centralized bidding (Announcement No.: 2022-003) on January 18, 2022. Panxin investment plans to reduce no more than 9735218 shares of the company through centralized bidding, and the reduction period is within six months after 15 trading days from the date of disclosure of the announcement.
2. As of the date of signing this report, Panxin investment has implemented the above reduction plan.
3. As of the signing date of this report, the information disclosure obligor will reduce its shares of the company through centralized bidding in the next 12 months according to the above reduction plan according to market conditions, stock price and other factors. In addition to the above reduction plan, as of the signing date of this report, the information disclosure obligor does not rule out the possibility of continuing to reduce or increase the shares of the listed company on the basis of complying with and complying with the existing effective laws, regulations and normative documents in the next 12 months. In case of relevant equity changes, the information discloser will perform the obligation of information disclosure in strict accordance with relevant regulations.
Section IV changes in equity
1、 Number and proportion of shares owned by the information disclosure obligor in the listed company
Before this equity change, Panxin investment held 10248062 shares of Shanghai Zj Bio-Tech Co.Ltd(688317) non tradable shares, accounting for 5.26% of the total share capital of the company, which is a shareholder holding more than 5% of the company. After this equity change, as of the signing date of this report, Panxin investment holds 9735062 shares, all of which are non tradable shares, accounting for 4.9999% of the total share capital of the company.
2、 Changes in equity this time
In this equity change, the details of the equity change of the information disclosure obligor are as follows:
Shareholder’s name reduction method change time price range reduction of shares in total share capital (yuan / share) (share)
Panxin investment centralized bidding 2022.2.22 – 2022.2.23 37.12-38.29 513000 0.26%
Total / / 513000 0.26%
Before and after this equity change, the changes in shares of listed companies held by information disclosure obligors are as follows:
Shares held before this change shares held after this change
Name of shareholder nature of shares number of shares held
Proportion of (shares) in total share capital proportion of (shares) in total share capital
Panxin investment’s tradable shares with unlimited sales conditions 10248062 5.26% 9735062 4.9999%
Total 10248062 5.26% 9735062 4.9999%
3、 Is there any right restriction on the equity shares owned by the information disclosure obligor in the company
condition
As of the signing date of this report, the shares of the company held by the information disclosure obligor are tradable shares with unlimited sales conditions, and there are no rights restrictions, including but not limited to the pledge, freezing or other rights restrictions of the shares.
Section V Trading of shares of Listed Companies in the first six months
Shareholder name reduction method reduction time type of shares price range proportion of reduced shares in total share capital (yuan / share) (share)
Panxin investment block trading: RMB 2022.1.18 ordinary shares 53.77 8235400 4.23%
Panxin investment block transaction 2022.1.19 RMB 55.85 1500000.77% of ordinary shares
Panxin investment block transaction 2022.1.27 RMB common stock 40.11 9735400 5.00%
Panxin investment block transaction 2022.2.10 RMB 36.80 9735400 ordinary shares 5.00%
Total / / 29206200 15.00%
The information disclosure obligors made the disclosure on January 18, 2022, January 19, 2022, January 27, 2022 and February 2022
On the 10th, a total of 29206200 shares of the company were reduced through block trading, accounting for% of the total share capital of the company
15.00%。 See Shanghai Zj Bio-Tech Co.Ltd(688317) on the website of Shanghai Stock Exchange (www.sse. Com. CN.) for details Disclosed
Tips on the reduction of more than 1% of shares held by Pan Xin (Shanghai) Equity Investment Center (limited partnership), a shareholder holding more than 5%
Public announcement (Announcement No.: 2022-005), customs
